Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Mohammad Hout

Urology Bridgeport, WV Medical Doctor

NPI 1508483496 CMS profile 7708840

327 Medical Park Dr, Bridgeport, WV 26330

Open in the dashboard

General payments

$4,683

25 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mohammad Hout of Bridgeport, WV is reported in the CMS Open Payments database as having received $4,683 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $109 3
2024 General $910 5
2023 General $3,639 16
2022 General $25 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mohammad Hout
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Mohammad Hout were reported at $109. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Mohammad Hout Urology median Middle half National median
2019 $0 $480 $147–$1,201 $163
2020 $0 $246 $87–$645 $114
2021 $0 $358 $111–$1,000 $132
2022 $25 $476 $143–$1,263 $149
2023 $3,639 $560 $168–$1,461 $160
2024 $910 $563 $170–$1,464 $164
2025 $109 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Intuitive Surgical, Inc. $3,197 9 payments
  2. Boston Scientific Corporation $1,069 7 payments
  3. Teleflex LLC $97 1 payment
  4. Laborie Medical Technologies Corp. $79 1 payment
  5. AstraZeneca Pharmaceuticals LP $61 2 payments
  6. CONMED Corporation $48 1 payment
  7. Stryker Corporation $42 1 payment
  8. W. L. Gore & Associates, Inc. $37 1 payment
  9. 180 Medical, Inc. $32 1 payment
  10. Urogen Pharma, Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $3,550 10 payments
  2. Food and Beverage $1,075 13 payments
  3. Education $35 1 payment
  4. Gift $23 1 payment
Products named General payments · program years 2022–2025
  1. Da Vinci Surgical System $2,376 8 payments
  2. Moses 550 D\F\L $1,006 6 payments
  3. DA VINCI SP $821 1 payment
  4. UROLIFT $97 1 payment
  5. LithoVue $63 1 payment
  6. AIRSEAL $48 1 payment
  7. 1788 $42 1 payment
  8. GORE SYNECOR Biomaterial $37 1 payment
  9. IMFINZI $35 1 payment
  10. FASENRA $25 1 payment
  11. Other $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

1,073

Median for Urology: 1,053

Drug cost

$90,952

Median for Urology: $101,464

Branded share of claims

25.3%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 84 $71,535
Tamsulosin Hcl Generic 307 $3,267
Fosfomycin Tromethamine Generic 11 $2,838
Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst Brand 53 $2,309
Dutasteride Generic 36 $2,307
Finasteride Generic 168 $2,042
Oxybutynin Chloride Er Oxybutynin Chloride Brand 79 $1,508
Solifenacin Succinate Generic 31 $1,424
Silodosin Generic 14 $904
Potassium Citrate Er Potassium Citrate Brand 12 $675

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 66 billing codes

Paid by Medicare

$84,889

Medicare's payments for the services billed

Medicare patients

354

Average age 74

Services billed

723

92 women, 262 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Diabetes 36%
Ischemic heart disease 36%
Cancer 35%
COPD 29%
Chronic kidney disease 27%
Depression 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record